Results 181 to 190 of about 181,538 (267)

Salvage of a severed Paul Glaucoma Implant tube via anastomosis with an Ahmed Glaucoma Valve in a child with Sturge-Weber syndrome and complicated glaucoma: a case report. [PDF]

Int J Surg Case Rep
Bamefleh D, Halawani M, Alotaibi H, AlBazei A, Alqurashi A.   +4 more
europepmc   +1 more source

Duration‐Dependent Efficacy and Clinical Safety of Repeated Low‐Level Red‐Light Therapy for Paediatric Myopia: A Systematic Review and Meta‐Analysis

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Repeated low‐level red‐light (RLRL) therapy is a novel, non‐invasive intervention for controlling paediatric myopia progression. Despite increasing clinical use, questions remain regarding the magnitude, durability, and safety of treatment effects.
Lee‐Yuan Lin, Cheng‐Hao Hsu, Hung Su, Jia‐Wei Sun, Jie‐Syuan Wu, Wei‐Jung Jeng, Chen‐Hsin Tsai, Fara Silvia Yuliani, Shyh‐Hsiang Lin   +8 more
wiley   +1 more source

A Comprehensive Review of the Clinical Evidence Comparing Benzalkonium Chloride-Preserved and Benzalkonium Chloride-Free Latanoprost in the Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension. [PDF]

Clin Ophthalmol
Kumar H, Parikh R, Chagani A, Bhojani KG, Jain P, Dharmadhikari S, Bhargave C, Mane A, Mehta S.   +8 more
europepmc   +1 more source

Long‐Term Local Control and Mortality After Transpupillary Thermotherapy of Small Uveal Melanomas

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Transpupillary thermotherapy (TTT) is used for selected small choroidal melanocytic tumours, either as primary treatment or as an adjunct to plaque brachytherapy. We compared long‐term local recurrence and mortality outcomes after primary TTT alone, plaque brachytherapy combined with TTT (brachy+TTT), and plaque brachytherapy alone (
Maria Fili, Malin Ermedahl Conradi, Maya Klaff Dahl, Shiva Sabazade, Manuel Casselholm De Salles, Gustav Stålhammar   +5 more
wiley   +1 more source

RANKL Inhibition and the Risk of Ocular Hypertension and Primary Open-Angle Glaucoma. [PDF]

Invest Ophthalmol Vis Sci
Tsai CY, Weng CH, Sheen YJ, Chen JP, Chen HM, Tsai CY, Wang IJ, Chou CC.   +7 more
europepmc   +1 more source

Aqueous Humour Cytokines as Predictors of Axial Elongation in High Myopia: A 2‐Year Longitudinal Cohort Study

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To investigate the predictive value of aqueous humour cytokines for axial elongation. Methods This was a prospective longitudinal observational study. 72 high myopia patients (72 eyes) who received implantable collamer lens (ICL) implantation surgery with at least 2 years of follow‐up were included.
Lihui Meng, Yan Luo, Zhengming Shi, Youxin Chen, Zhikun Yang   +4 more
wiley   +1 more source

Zeb2 Controls Retinal Physiological and Pathological Angiogenesis by Regulating Astrocyte Proliferation and Differentiation

Cell Proliferation, EarlyView.
During development, the oxygen‐sensitive transcription factor Zeb2 restrains astrocyte proliferation and maturation to ensure balanced retinal angiogenesis. In disease, it promotes the neurotoxic A1 astrocyte phenotype and inflammation, thereby promoting reparative revascularization over pathological neovascularization.
Jing Liu, Yanan Guo, Kangjian Xiang, Shuyi Wang, Dongchang Xiao, Mengqing Xiang   +5 more
wiley   +1 more source

The Metabolic Architecture of Glaucoma: A Unified Framework of Cofactor Failure and Kynurenine Dysregulation. [PDF]

Int J Mol Sci
Caikovska L, Veitners A, Lavrinovica D, Vanags J, Klavins K, Laganovska G, Zemitis A.   +6 more
europepmc   +1 more source

Pharmacological Therapy of Glaucoma with Special Focus on Monoclonal Antibodies

Glaucoma is a complex and progressive optic neuropathy characterized by retinal ganglion cell (RGC) degeneration and optic nerve damage, ultimately leading to irreversible vision loss.
Sigalov, Ron
core  

Adherence to the Mediterranean Diet by Greek Patients With Glaucoma: An Observational Study. [PDF]

Cureus
Vlachogianni IC, Chatzistefanou KI, Droutsas K, Moschos MM.   +3 more
europepmc   +1 more source